Skip to content

FASYLPHARMA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

FASYLPHARMA

BE 0478.056.184
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€15,509
2024 · €26,802-€11,293
Equity
€234,342
2024 · €218,833+€15,509
Cash
€85,763
2024 · €102,826-€17,063
Balance sheet total
€250,318
2024 · €284,875-€34,558

Largest movements

2024 to 2025
Assets
  • Cash -€17,063

    down €17,063 (-16.6%), from €102,826 to €85,763

    mainly Other debts (-€29,969) and Current portion of long-term debt (-€23,192)

  • Tangible fixed assets -€12,446

    down €12,446 (-20.3%), from €61,340 to €48,894

    of which Furniture and vehicles: -€8,970

  • Deferred charges and accrued income -€8,685

    down €8,685 (-31.9%), from €27,214 to €18,529

  • Stocks and contracts +€7,508

    up €7,508 (+9.8%), from €76,428 to €83,936

  • Receivables within one year -€3,872

    down €3,872 (-22.7%), from €17,067 to €13,195

    of which Other amounts receivable: -€11,506

Equity and liabilities
  • Other debts -€29,969

    down €29,969 (-99.9%), from €30,000 to €31

  • Current portion of long-term debt -€23,192

    down €23,192 (-90.0%), from €25,769 to €2,576

  • Reserves +€15,509

    up €15,509 (+9.7%), from €159,712 to €175,221

    of which Distributable reserves: +€15,509

  • Tax, wage and social debts +€5,092

    up €5,092 (+1053.6%), from €483 to €5,576

    of which Remuneration and social security: +€3,542

Income statement
  • Gross operating margin -€13,860

    down €13,860 (-26.0%), from €53,232 to €39,372

  • Taxes -€2,746

    down €2,746 (-26.6%), from €10,322 to €7,576

  • Financial charges +€1,001

    up €1,001 (+76.2%), from €1,314 to €2,315

  • Other operating charges -€840

    down €840 (-35.3%), from €2,380 to €1,539

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €26,802
Gross operating margin -€13,860
Other operating charges +€840
Financial income -€18
Financial charges -€1,001
Taxes +€2,746
Result 2025 €15,509

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€8,706
Investment €0
Financing -€25,769
Cash 2024 €102,826
Net result for the year +€15,509
Depreciation +€12,446
Stocks and contracts -€7,508
Receivables within one year +€3,872
Deferred charges and accrued income +€8,685
Trade debts +€578
Tax, wage and social debts +€5,092
Other debts -€29,969
Debts after one year -€2,576
Current portion of long-term debt -€23,192
Cash 2025 €85,763
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €284,875 €250,318 -€34,558 -12.1%
Fixed assets 21/28 €61,340 €48,894 -€12,446 -20.3%
Tangible fixed assets 22/27 €61,340 €48,894 -€12,446 -20.3%
Land and buildings 22 €49,469 €45,993 -€3,476 -7.0%
Furniture and vehicles 24 €11,871 €2,902 -€8,970 -75.6%
Current assets 29/58 €223,535 €201,423 -€22,112 -9.9%
Stocks and contracts in progress 3 €76,428 €83,936 +€7,508 +9.8%
Stocks 30/36 €76,428 €83,936 +€7,508 +9.8%
Amounts receivable within one year 40/41 €17,067 €13,195 -€3,872 -22.7%
Trade receivables 40 €1,587 €9,220 +€7,634 +481.2%
Other amounts receivable 41 €15,481 €3,975 -€11,506 -74.3%
Cash at bank and in hand 54/58 €102,826 €85,763 -€17,063 -16.6%
Deferred charges and accrued income 490/1 €27,214 €18,529 -€8,685 -31.9%
Total equity and liabilities 10/49 €284,875 €250,318 -€34,558 -12.1%
Equity 10/15 €218,833 €234,342 +€15,509 +7.1%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €159,712 €175,221 +€15,509 +9.7%
Tax-exempt reserves 132 €12,400 €12,400 = 0.0%
Distributable reserves 133 €147,312 €162,821 +€15,509 +10.5%
Profit (loss) carried forward 14 €52,920 €52,920 = 0.0%
Amounts payable 17/49 €66,043 €15,976 -€50,067 -75.8%
Amounts payable after more than one year 17 €2,576 - -€2,576
Financial debts 170/4 €2,576 - -€2,576
Amounts payable within one year 42/48 €63,466 €15,976 -€47,490 -74.8%
Current portion of amounts payable after more than one year 42 €25,769 €2,576 -€23,192 -90.0%
Trade debts 44 €7,214 €7,792 +€578 +8.0%
Suppliers 440/4 €7,214 €7,792 +€578 +8.0%
Taxes, remuneration and social security 45 €483 €5,576 +€5,092 +1053.6%
Taxes 450/3 €483 €2,034 +€1,551 +320.9%
Remuneration and social security 454/9 - €3,542 +€3,542
Other amounts payable 47/48 €30,000 €31 -€29,969 -99.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €12,446 €12,446 = 0.0%
Other operating charges 640/8 €2,380 €1,539 -€840 -35.3%
Gross operating margin 9900 €53,232 €39,372 -€13,860 -26.0%
Operating profit (loss) 9901 €38,406 €25,387 -€13,020 -33.9%
Financial income 75/76B €32 €14 -€18 -56.3%
Recurring financial income 75 €32 €14 -€18 -56.3%
Financial charges 65/66B €1,314 €2,315 +€1,001 +76.2%
Recurring financial charges 65 €1,314 €2,315 +€1,001 +76.2%
Profit (loss) for the period before taxes 9903 €37,124 €23,085 -€14,039 -37.8%
Income taxes 67/77 €10,322 €7,576 -€2,746 -26.6%
Profit (loss) for the period 9904 €26,802 €15,509 -€11,293 -42.1%
Profit (loss) for the period to be appropriated 9905 €26,802 €15,509 -€11,293 -42.1%

Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.